RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Urinary Tract Cancer - Pipeline Review, Q3 2011
Jul 2011 - 296 pages - $500
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2010
Aug 2010 - 76 pages - $1,500
Novartis AG: PharmaVitae Profile
Apr 2011 - 129 pages - $3,800
Apotex Inc.: PharmaVitae Profile
Dec 2010 - 37 pages - $5,700
Urinary Tract Cancer - Pipeline Review, Q1 2011
Jan 2011 - 23 pages - $500
Epidemiology: Urinary Incontinence - Female urinary incontinence will continue to be highly prevalent due to global population growth patterns
Jan 2011 - 45 pages - $5,700
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - June 2010
Jun 2010 - 67 pages - $1,000
H. Lundbeck A/S: PharmaVitae Profile
Dec 2010 - 58 pages - $5,700
Teva Pharmaceutical Industries Ltd: PharmaVitae Profile
Mar 2009 - 59 pages - $5,700
Menarini: PharmaVitae Profile
Jun 2010 - 48 pages - $5,700
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Prescription del
Therapeutic target
Genito-urinary del
Year
2011 del

Browse By

Therapeutic target
Gender related medicine female
Gender related medicine male
Genito-urinary other
Paget's disease
Sexually transmitted diseases
Urinary

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us